Cargando…
Aconine attenuates osteoclast-mediated bone resorption and ferroptosis to improve osteoporosis via inhibiting NF-κB signaling
Osteoporosis (OP), a prevalent public health concern primarily caused by osteoclast-induced bone resorption, requires potential therapeutic interventions. Natural compounds show potential as therapeutics for postmenopausal OP. Emerging evidence from in vitro osteoclastogenesis assay suggests that ac...
Autores principales: | Xue, Chunchun, Luo, Huan, Wang, Libo, Deng, Qing, Kui, Wenyun, Da, Weiwei, Chen, Lin, Liu, Shuang, Xue, Yongpeng, Yang, Jiafan, Li, Lingxing, Du, Wenlan, Shi, Qi, Li, Xiaofeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682992/ https://www.ncbi.nlm.nih.gov/pubmed/38034017 http://dx.doi.org/10.3389/fendo.2023.1234563 |
Ejemplares similares
-
Screening diagnostic markers of osteoporosis based on ferroptosis of osteoblast and osteoclast
por: Cao, Zhihai, et al.
Publicado: (2023) -
A bone-resorption surface-targeting nanoparticle to deliver anti-miR214 for osteoporosis therapy
por: Cai, Mingxiang, et al.
Publicado: (2017) -
Up‐regulated CST5 inhibits bone resorption and activation of osteoclasts in rat models of osteoporosis via suppression of the NF‐κB pathway
por: Wang, Fei, et al.
Publicado: (2019) -
Osteoclasts secrete osteopontin into resorption lacunae during bone resorption
por: Luukkonen, Jani, et al.
Publicado: (2019) -
Effects of ibandronate-hydroxyapatite on resorptive activity of osteoclasts
por: Zhang, Xiaohui, et al.
Publicado: (2011)